Zhi-Ming Shao, Ruoxi Wang, Ruijun Zhao, Yang Yu, Quchang Ouyang, Yu Ren, Jun Huang, Yongzhong Yao, Jin Zhang, Aimei Jiang, Hui Li, Hao Zhang, Jianyun Nie, Qiao Cheng, Tingjing Yao, Shanshan Gu, Yanyan Hou, Tianyu Ren, Beisong Liu, Jianmin Fang. "Efficacy and safety of neoadjuvant disitamab vedotin (DV) in combination with toripalimab (Tor) and concurrent/sequential chemotherapy (chemo) in patients with HR-negative, HER2-low breast cancer: A randomized multicenter phase 2 study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.598